Getty ImagesThe stock opened at Rs 127.05 and touched an intraday high and low of Rs 128.1 and Rs 125.9, respectively, in the session so far. Shares of the company of GAIL (India) Ltd. quoted a 52-week high of Rs 128.1 and a 52-week low of Rs 83.0.
As per BSE, the total market cap of the GAIL (India) Ltd. stood at Rs 84194.15 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 33000.79 crore for the quarter ended 30-Jun-2023, down 2.23 per cent from previous quarter's Rs 33753.23 crore and down 13.13 per cent from the year-ago quarter's Rs 37987.96 crore.
The net profit for latest quarter stood at Rs 1791.85 crore, down 44.92 per cent from the same quarter a year ago.
As of 30-Jun-2023, DIIs held 8.26 per cent stake in the firm, while foreign institutional investors held 15.97 per cent and the promoters 51.52 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 20.26 and a price-to-book ratio of 1.07. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
GAIL (India) Ltd. belongs to the Gas Distribution industry.
Friday, 08 Sep, 2023- Front Page
- Pure Politics
- ET Markets
- Smart Investing
- Learn more about our print editionMore
IT Hardware Imports Surge in Aug after Licensing OrderIndia’s IT hardware imports surged as much as 50% in August from July, ahead of licensing rules taking effect on November 1. Companies advanced procurements fearing a supply crunch, said manufacturers and a leading system integrator that buys from distributors and producers and supplies to enterprises.
‘Look to Export AI Products from Nvidia India Arm’Nvidia, the world’s pre-eminent maker of hardware and software for artificial intelligence tools, envisions exporting AI products from its Indian arm, CEO and co-founder of the $27-billion firm, Jensen Huang told researchers at India’s top technology institutes this week, according to the people present at the interaction.
DCGI Collating Data of Pharma PlantsAfter a major drive by the government against spurious and substandard drugs, India’s drug regulator has started collating and compiling the profiles of pharmaceutical plants in the country.The Drug Controller General of India (DCGI) has asked drug companies to provide details of each of their units operational in the country.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: Sensex Today Live, SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Get Unlimited Access to The Economic Times 
